Aliya PEF ablation for Non-Small Cell Lung Cancer

Phase-Based Progress Estimates
Mayo Clinic Rochester, Rochester, MNNon-Small Cell Lung CancerAliya Pulsed Electric Fields (PEF) ablation - Device
All Sexes
What conditions do you have?

Study Summary

This trial will study the effects of a cancer treatment combining chemotherapy, immunotherapy, and electric fields on lung cancer.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Surgical resection

Surgical resection
Pathologic response
Heart rate

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

1 Treatment Group

Aliya PEF ablation
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Aliya PEF ablation · No Placebo Group · Phase 4

Aliya PEF ablationExperimental Group · 4 Interventions: Aliya Pulsed Electric Fields (PEF) ablation, Nivolumab plus Platinum Doublet Chemotherapy, Standard of care neoadjuvant therapy, Surgical Resection · Intervention Types: Device, Drug, Drug, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: surgical resection

Who is running the clinical trial?

Galvanize Therapeutics, Inc.Lead Sponsor
2 Previous Clinical Trials
42 Total Patients Enrolled
William Krimsky, MDStudy ChairChief Medical Officer
3 Previous Clinical Trials
128 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The area being studied can be safely and accurately biopsied and treated based on the investigator's judgement.
A qualified study investigator thinks you might need surgery to remove lung tissue.
You are physically able to safely undergo general anesthesia.

Frequently Asked Questions

Is Aliya PEF ablation hazardous for people's health?

"Aliya PEF ablation has been approved and is thus rated a 3 on the 1-3 scale of safety." - Anonymous Online Contributor

Unverified Answer

Are researchers currently seeking more participants for this trial?

"According to records from, this research project is no longer recruiting candidates - the initial post was made on November 1st of 2022 and it has since been duly updated as recently as October 24th of 2022. However, there are currently 1529 other trials that are still enrolling patients for participation." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.